Product NewsPowderMed’s Therapeutic DNA Vaccine for Chronic Hepatitis B Enters Phase I Clinical Trials in Patients
Product NewsTopoTarget and CuraGen announce initiation of first NCI-sponsored clinical trial with PXD101
Product NewsNew PharmaMedDevice™ Conference and Exhibition Focuses on the Convergence of Medical Device, Pharmaceutical and Biologic Industries
Product NewsAblynx reveals power of Nanoclone™ - A high throughput method for isolating highly potent antibody-derived therapeutic proteins (Nanobodies™)
Product NewsNew CD136 (RON)-PE RUO Monoclonal Antibody Identifies Potential Marker of Epithelial Cells
Product NewsPremière homologation, par la FDA, de Rituxan (MabThera) dans le traitement de la polyarthrite rhumatoïde
Product NewsMalignant melanoma identified as disease target for YP004, York Pharma’s skin cancer programme
Product NewsTopoTarget initiates pivotal Phase II trial with Savicol™ for FAP (an inherited pre-disposition to develop colon cancer)
Product NewsHybrigenics acquiert les droits internationaux pour l’inecalcitol, un analogue de vitamine D
Product NewsOxford Immunotec’s T-SPOT.TB is first test to demonstrate accurate diagnosis of latent TB in HIV patients
Product NewsNew Technology for Accelerating Development of Vaccines Against H5N1 Flu Enters Pilot Study at ProImmune
Product NewsCobra Biomanufacturing signs agreement with Debiopharm to supply biopharmaceutical protein
